A Cannabis Retailer’s Guide to Reducing Shrink and Inventory Variances - Get the Free Guide Now
A Cannabis Retailer’s Guide to Reducing Shrink and Inventory Variances - Get the Free Guide Now
Cannabis Business Times On 'Jersey Matters' | Cannabis Business Times

Sign in or create a free Cannabis Business Times account to continue reading

Continue to Site »
Site will load in 15 seconds

Cannabis Business Times On 'Jersey Matters'

Cannabis Business Times Editor Noelle Skodzinski speaks with Larry Mendte on "Jersey Matters" about the magazine's focus on the growth of the industry and the future of cannabis legalization.

May 17, 2016
Recommended
Shrink Is Eating Into Cannabis Retail Margins - Here’s How to Stop It
Shrink Is Eating Into Cannabis Retail Margins - Here’s How to Stop It
Seth Goldberg Opinion
Closing the Hemp Loophole Does Not Mean Your Business Has to Close (Opinion)
Vee Display Pexels Mikhail Nilov 9159037
Cannabis Workforce Solutions: How Licensed Cultivators, Dispensaries Benefit From Industry-Education Alliances (Opinion)
Orville Bovenschen Village Farms Canadian Cannabis Top Story Image
The Race to Nowhere: How Chasing Potency Undermines Cannabis Quality (Opinion)
Related Stories
Maher030216
Bill Maher Talks Marijuana Legalization
012016 Cbt 4th Corner
Interview: Mark Goldfogel on Fourth Corner Credit Union Case Dismissal
Webblank010416
2016 Will Be the Biggest Year Yet for Marijuana Policy Reform
Ytkasich111615
Stephen Colbert Grills John Kasich on Marijuana Legalization
More in Interviews & Opinion
The Biggest Things About Schedule III You Haven’t Thought Of
Brian Vicente of Vicente LLP talks Schedule III with Cannabis Business Times
America Mj 679861553
Closing the Hemp Loophole Does Not Mean Your Business Has to Close (Opinion)
Potential changes to the 2018 Farm Bill’s definition of hemp, if enacted, mean businesses will have one year to adapt their operations.
Seth Goldberg Opinion
Cannabis Workforce Solutions: How Licensed Cultivators, Dispensaries Benefit From Industry-Education Alliances (Opinion)
As the cannabis industry matures, the integration of targeted workforce and business development training will be essential.
Vee Display Pexels Mikhail Nilov 9159037
The Race to Nowhere: How Chasing Potency Undermines Cannabis Quality (Opinion)
The current THC labeling system is misleading, and consumers deserve more accurate, meaningful information.
Orville Bovenschen Village Farms Canadian Cannabis Top Story Image
German Cannabis Market Establishes Foundation for Global Industry Expansion (Op-Ed)
The fact that legal cannabis in Germany is more affordable than the illegal market is revolutionary for the global cannabis industry to date.
Germany Graphic
Innovating for the Benefit of Patients in Medical Cannabis (Opinion)
Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.
Stenocare 365250395
Rescheduling Update: How Long Is the Wait? What’s Next?
Government affairs and policy expert David Mangone tells us what we can expect from the DEA as weeks pass following the public comment period, including insights on the DEA’s final review and if a hearing is likely to be granted.
David Mangone Interview Top Story Image
Mitch Meyers on How to 'Manage the Chaos' in Cannabis
The founder of Missouri's BeLeaf Medical says women are 'uniquely suited' to be leaders in the male-dominated industry.
Mitch Meyers, founder, BeLeaf Medical
7 Takeaways From the Feds' Cannabis Rescheduling Recommendation
Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.
Opinion Top Story Havens 948x514
Opinion: The Cannabis Industry Must Prioritize Worker Safety, Invest in PPE
The hazards associated with cannabis production are well-documented, and it's time for the industry to step up and prioritize the health and safety of its employees.
Opinion Top Story Roggen 948x514
Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit
After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."
A screenshot of the redacted letter from the U.S. Department of Health and Human Services Cannabis Business Times received in response to its Freedom of Information Act Request.
A Positive Sign For Schedule III
In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.
Opinion Top Story Pennington
Page 1 of 51
Next Page